Screener
Eligibility screening
A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensiv…
35 US sites in AR, AZ, CA, CO +17
Before we begin
Who are you filling this out for?
Your answer affects how the questions are phrased.